BackIntegrated BioPharma Overview

Integrated BioPharma Inventory

Integrated BioPharma's inventory is $9.1M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$9.14M
↓ 2.35% YoYΔ $-220000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Integrated BioPharma Inventory History

Loading

Integrated BioPharma vs. peers: Inventory Comparison

Loading

Integrated BioPharma Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Integrated BioPharma (INBP) FAQ

The latest inventory for INBP is $9.1M as of June 2026. That compares with $9.4M in the prior-year period — down 2.3% year over year. Investors often review this figure alongside Integrated BioPharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, INBP's inventory moved from $9.4M to $9.1M — a 2.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Integrated BioPharma's operating scale or balance-sheet position.

A inventory figure of $9.1M for INBP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting INBP's inventory ($9.1M), review year-over-year change from $9.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.